When Cancer Patients Should Ask For Genetic Sequencing

Hepatitis C a baby boomer target 
June 2, 2017
Celgene touts ozanimod MS data, but disability benefit weak over rival drug
June 2, 2017
Show all

When Cancer Patients Should Ask For Genetic Sequencing

Understanding the DNA of cancer could lead to better cancer treatments.

Cancer DNA can provide important clues about the best way to treat the disease, finds a new study published in the journal Nature Medicine.

Doctors can genetically profile tumors by sequencing the DNA from a person’s cancer cells, revealing which mutations are responsible for causing the cancer. By comparing the tumor’s DNA to DNA from the same person’s healthy cells, the scientists can pinpoint which genetic changes were unique to the cancer cells.

In the new research, scientists at Memorial Sloan Kettering Cancer Center (MSKCC) sequenced more than 10,000 tumor biopsies and found that 37% of the people had at least one mutation that could be addressed, either with a prescription for an existing cancer drug or by taking part in a clinical trial testing new therapies. Other patients learned that they could take advantage of some of the newer immune-based therapies that are showing great promise.

Read full article: When Cancer Patients Should Ask For Genetic Sequencing | Time.com

Read Full Article: When Cancer Patients Should Ask For Genetic Sequencing | Time.com

The health and medical information on our website is not intended to take the place of advice or treatment from health care professionals. It is also not intended to substitute for the users’ relationships with their own health care/pharmaceutical providers.

Comments are closed.